Ajay Kapoor

1614335227

COVID 19 Vaccine Rollout And Tracking: AI Is Speeding Up | Experfy.com

source

The Pfizer and the Moderna vaccines are in the market, and the clinical trials have already begun showing amazing results. But, the dilemma is that of the rollout of the vaccine.Does the governments of nations have the potential for quick distribution of the vaccine?

Pfizer and Moderna leveraged cutting-edge science to develop the vaccine, and it seems that it is again the technology that will go parallelly until the vaccine shots are given to every needy.

A recent account in devex shows that AI development can help the COVID 19 vaccine reach nearly 80 percent of the global population who currently live in low and middle-income countries, which is almost 2 billion people.

We human beings cannot take thousands of competing and evolving factors into consideration, and this is where AI comes into play. Since the beginning of the COVID19 pandemic, AI and other digital tools have crunched thousands of scientific papers to develop the vaccine. This time, AI is there to process the data much faster than humans can and speed up the vaccine roll out and tracking.

This post will see how pharmaceutical companies can use AI approaches, recommendations, and strategies to make a difference in the vaccine rollout. Before this, let’s have a look at the four distinct areas in which AI plays a major role.

•Triage and impact modeling
The AI technology helps figure out the needy from the population group who quickly needs to be vaccinated to end the COVID 19 pandemic.

•Demand forecasting
It determines the areas where the vaccine needs to be shipped and when they need it. This will help the needy masses to be vaccinated in the least amount of time.

•Supply chain management
Monitors the production of the doses and delivery network to avoid bottlenecks in supply chain management.

•Post-vaccination supervision
There might be some post adverse side effects from the trial; AI watches out for those signs and informs the relevant authorities about them.

Pharmaceuticals giant exploring the role of AI in the vaccine rollout.
Genpact, UK
With the help of Genpact A, the UK government can track events by batch, lot, and location much easier than humans can do. AI can track issues such as ethnicity, gender, age, and other demographic factors that can affect doses.

“AI can handle thousands of dimensions of data and find patterns and signals in the data very rapidly, something that would take humans much longer to find.”

Pharmaceutical companies are exploring AI’s role in the availability, procurement, tracing, delivery logistics, and storage of the vaccine in supply chain management.

Now let talk about the main benefits of AI in Covid 19 vaccine rollout & tracking:

  1. Figures out the reaction of the population
    After the COVID 19 vaccine rollout among the population worldwide, AI will help us see the entire scene and the possible adverse effects caused by it. It will provide insights into the patients’ reactions after the vaccination based on their demographic information and medical history.

  2. Vaccine reporting process
    AI informs about the vaccine reporting process because this process has multiple steps for accurate reporting of data. It allows for less inspection by humans and sinks the data onto one plane. This prevents the healthcare institutions from building reports for multiple EHR (Electronic Health Records) or pharmacy systems.

  3. Ensures continuous supply
    AI systems ensure a continuous supply to avoid complexity in the supply chain. It allows for real-time visibility of the supply chain performance and provides autonomous supply operations to allocate materials and distribute products.

  4. RPA bot well-positioned to now help track flu vaccinations in the UK
    The NHS is now reviewing plans to extend the technology to report on COVID-19 vaccinations, recently approved to be administered in the UK. NHS Foundation Trust in the UK uses the AI tool to track the COVID 19 vaccine rollout, which has been earlier deployed to track flu vaccinations in the UK.

The flu-reporting bot is making use of the AI tool to improve data accuracy and ensures that the valuable time is not diverted from supporting staff and patient care.”

  1. AI communicates well
    Artificial Intelligence targets messages and helps in connecting with needy citizens. AI customizes the message’s content that motivates the citizens to take the vaccine by looking at the profession and vulnerability of the masses.

The technology personalizes the messages that help citizens access the vaccine either by phone call, website, or text.

  1. AI helps in healthy decision-making
    Healthcare workers often see the COVID 19 vaccine’s distribution process on a macro-level, but the scene is quite different. We need to analyze it on a smaller scale because we can better allocate the vaccines within a state, locations, and subpopulations.

AI-augmented simulations help roll out the vaccine in a dozen locations within a state by considering several factors that include hundred of inputs, hospital utilization, mobility data, and current infection rates.

In such a mass, the bot will prove itself to be a good decision-maker as it will send the vaccines to those in utmost need. But, with AI, the developers need to understand the pattern to avoid bias.

  1. AI-based chatbots
    AI-infused chatbots are a great example of AI’s application in COVID vaccine rollout. The bots address the COVID 19 questions through the population’s existing voice, chat, or social media channels.

Tony Bates, the CEO of Genesys, says that their company has released COVOD-19 vaccine response, a digital solution that will enable the companies to use AI-enabled chatbots.

The bot will address the requests for information from more than 330 million people in states.

Final Words
AI has become an integral part of the digital industry and now the pharmaceutical industry as well. With the COVID 19 vaccine rollout, AI has proved to be the catalyst in time-saving and efficacy capabilities.

41 percent of the healthcare executives from the pharmaceutical industry have reported that AI is one such technology that has the most significant impact on them since the time vaccine has been in the market. It has empowered human healthcare professionals and helped them work faster and better.

It‘s the right time when the healthcare sector dealing with COVID 19 vaccine rollout shipment should cherish and adapt the benefits in COVID vaccine rollout and hire AI developers to leverage this technology’s power.

#corona #covid #covid-vaccine #ai #artificial-intelligence

What is GEEK

Buddha Community

COVID 19 Vaccine Rollout And Tracking: AI Is Speeding Up | Experfy.com

Data Scientist Creates Python Script To Track Available Slots For Covid Vaccinations

Bhavesh Bhatt, Data Scientist from Fractal Analytics posted that he has created a Python script that checks the available slots for Covid-19 vaccination centres from CoWIN API in India. He has also shared the GitHub link to the script.

The YouTube content creator posted, “Tracking available slots for Covid-19 Vaccination Centers in India on the CoWIN website can be a bit strenuous.” “I have created a Python script which checks the available slots for Covid-19 vaccination centres from CoWIN API in India. I also plan to add features in this script of booking a slot using the API directly,” he added.

We asked Bhatt how did the idea come to fruition, he said, “Registration for Covid vaccines for those above 18 started on 28th of April. When I was going through the CoWIN website – https://www.cowin.gov.in/home, I found it hard to navigate and find empty slots across different pin codes near my residence. On the site itself, I discovered public APIs shared by the government [https://apisetu.gov.in/public/marketplace/api/cowin] so I decided to play around with it and that’s how I came up with the script.”

Talking about the Python script, Bhatt mentioned that he used just 2 simple python libraries to create the Python script, which is datetime and requests. The first part of the code helps the end-user to discover a unique district_id. “Once he has the district_id, he has to input the data range for which he wants to check availability which is where the 2nd part of the script comes in handy,” Bhatt added.

#news #covid centre #covid news #covid news india #covid python #covid tracing #covid tracker #covid vaccine #covid-19 news #data scientist #python #python script

Ajay Kapoor

1614335227

COVID 19 Vaccine Rollout And Tracking: AI Is Speeding Up | Experfy.com

source

The Pfizer and the Moderna vaccines are in the market, and the clinical trials have already begun showing amazing results. But, the dilemma is that of the rollout of the vaccine.Does the governments of nations have the potential for quick distribution of the vaccine?

Pfizer and Moderna leveraged cutting-edge science to develop the vaccine, and it seems that it is again the technology that will go parallelly until the vaccine shots are given to every needy.

A recent account in devex shows that AI development can help the COVID 19 vaccine reach nearly 80 percent of the global population who currently live in low and middle-income countries, which is almost 2 billion people.

We human beings cannot take thousands of competing and evolving factors into consideration, and this is where AI comes into play. Since the beginning of the COVID19 pandemic, AI and other digital tools have crunched thousands of scientific papers to develop the vaccine. This time, AI is there to process the data much faster than humans can and speed up the vaccine roll out and tracking.

This post will see how pharmaceutical companies can use AI approaches, recommendations, and strategies to make a difference in the vaccine rollout. Before this, let’s have a look at the four distinct areas in which AI plays a major role.

•Triage and impact modeling
The AI technology helps figure out the needy from the population group who quickly needs to be vaccinated to end the COVID 19 pandemic.

•Demand forecasting
It determines the areas where the vaccine needs to be shipped and when they need it. This will help the needy masses to be vaccinated in the least amount of time.

•Supply chain management
Monitors the production of the doses and delivery network to avoid bottlenecks in supply chain management.

•Post-vaccination supervision
There might be some post adverse side effects from the trial; AI watches out for those signs and informs the relevant authorities about them.

Pharmaceuticals giant exploring the role of AI in the vaccine rollout.
Genpact, UK
With the help of Genpact A, the UK government can track events by batch, lot, and location much easier than humans can do. AI can track issues such as ethnicity, gender, age, and other demographic factors that can affect doses.

“AI can handle thousands of dimensions of data and find patterns and signals in the data very rapidly, something that would take humans much longer to find.”

Pharmaceutical companies are exploring AI’s role in the availability, procurement, tracing, delivery logistics, and storage of the vaccine in supply chain management.

Now let talk about the main benefits of AI in Covid 19 vaccine rollout & tracking:

  1. Figures out the reaction of the population
    After the COVID 19 vaccine rollout among the population worldwide, AI will help us see the entire scene and the possible adverse effects caused by it. It will provide insights into the patients’ reactions after the vaccination based on their demographic information and medical history.

  2. Vaccine reporting process
    AI informs about the vaccine reporting process because this process has multiple steps for accurate reporting of data. It allows for less inspection by humans and sinks the data onto one plane. This prevents the healthcare institutions from building reports for multiple EHR (Electronic Health Records) or pharmacy systems.

  3. Ensures continuous supply
    AI systems ensure a continuous supply to avoid complexity in the supply chain. It allows for real-time visibility of the supply chain performance and provides autonomous supply operations to allocate materials and distribute products.

  4. RPA bot well-positioned to now help track flu vaccinations in the UK
    The NHS is now reviewing plans to extend the technology to report on COVID-19 vaccinations, recently approved to be administered in the UK. NHS Foundation Trust in the UK uses the AI tool to track the COVID 19 vaccine rollout, which has been earlier deployed to track flu vaccinations in the UK.

The flu-reporting bot is making use of the AI tool to improve data accuracy and ensures that the valuable time is not diverted from supporting staff and patient care.”

  1. AI communicates well
    Artificial Intelligence targets messages and helps in connecting with needy citizens. AI customizes the message’s content that motivates the citizens to take the vaccine by looking at the profession and vulnerability of the masses.

The technology personalizes the messages that help citizens access the vaccine either by phone call, website, or text.

  1. AI helps in healthy decision-making
    Healthcare workers often see the COVID 19 vaccine’s distribution process on a macro-level, but the scene is quite different. We need to analyze it on a smaller scale because we can better allocate the vaccines within a state, locations, and subpopulations.

AI-augmented simulations help roll out the vaccine in a dozen locations within a state by considering several factors that include hundred of inputs, hospital utilization, mobility data, and current infection rates.

In such a mass, the bot will prove itself to be a good decision-maker as it will send the vaccines to those in utmost need. But, with AI, the developers need to understand the pattern to avoid bias.

  1. AI-based chatbots
    AI-infused chatbots are a great example of AI’s application in COVID vaccine rollout. The bots address the COVID 19 questions through the population’s existing voice, chat, or social media channels.

Tony Bates, the CEO of Genesys, says that their company has released COVOD-19 vaccine response, a digital solution that will enable the companies to use AI-enabled chatbots.

The bot will address the requests for information from more than 330 million people in states.

Final Words
AI has become an integral part of the digital industry and now the pharmaceutical industry as well. With the COVID 19 vaccine rollout, AI has proved to be the catalyst in time-saving and efficacy capabilities.

41 percent of the healthcare executives from the pharmaceutical industry have reported that AI is one such technology that has the most significant impact on them since the time vaccine has been in the market. It has empowered human healthcare professionals and helped them work faster and better.

It‘s the right time when the healthcare sector dealing with COVID 19 vaccine rollout shipment should cherish and adapt the benefits in COVID vaccine rollout and hire AI developers to leverage this technology’s power.

#corona #covid #covid-vaccine #ai #artificial-intelligence

Abigail  Cassin

Abigail Cassin

1596574500

How The New AI Model For Rapid COVID-19 Screening Works?

With the current pandemic spreading like wildfire, the requirement for a faster diagnosis can not be more critical than now. As a matter of fact, the traditional real-time polymerase chain reaction testing (RT-PCR) using the nose and throat swab has not only been termed to have limited sensitivity but also time-consuming for operational reasons. Thus, to expedite the process of COVID-19 diagnosis, researchers from the University of Oxford developed two early-detection AI models leveraging the routine data collected from clinical reports.

In a recent paper, the Oxford researchers revealed the two AI models and highlighted its effectiveness in screening the virus in patients coming for checkups to the hospital — for an emergency checkup or for admitting in the hospital. To validate these real-time prediction models, researchers used primary clinical data, including lab tests of the patients, their vital signs and their blood reports.

Led by a team of doctors — including Dr Andrew Soltan, an NIHR Academic Clinical Fellow at the John Radcliffe Hospital, Professor David Clifton from Oxford’s Institute of Biomedical Engineering, and Professor David Eyre from the Oxford Big Data Institute — the research initiated with developing ML algorithms trained on COVID-19 data and pre-COVID-19 controls to identify the differences. The study has been aimed to determine the level of risk a patient can have to have COVID-19.

#opinions #covid screening #covid-19 news #covid-19 screening test #detecting covid

Otho  Hagenes

Otho Hagenes

1619511840

Making Sales More Efficient: Lead Qualification Using AI

If you were to ask any organization today, you would learn that they are all becoming reliant on Artificial Intelligence Solutions and using AI to digitally transform in order to bring their organizations into the new age. AI is no longer a new concept, instead, with the technological advancements that are being made in the realm of AI, it has become a much-needed business facet.

AI has become easier to use and implement than ever before, and every business is applying AI solutions to their processes. Organizations have begun to base their digital transformation strategies around AI and the way in which they conduct their business. One of these business processes that AI has helped transform is lead qualifications.

#ai-solutions-development #artificial-intelligence #future-of-artificial-intellige #ai #ai-applications #ai-trends #future-of-ai #ai-revolution

Aketch  Rachel

Aketch Rachel

1618099140

How Is TCS Helping With COVID-19 Testing In India

COVID-19 cases have only been on the rise. With the non-availability of effective drugs and vaccines, one of the effective ways to control it is to detect it early in patients. However, the task is easier said than done. While a large number of test kits are being produced, they are not enough to conduct testing in large numbers.

Government-run body, C-CAMP or Centre for Cellular and Molecular Platform, has been a key enabler in driving COVID-19 testing as it has been aggressively building, managing and scaling the ecosystem of MSMEs to produce test kits indigenously. However, they might not be enough.

#opinions #c-camp #c-camp tcs #covid-19 #covid-19 testing #tcs #tcs covid-19